SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Board Changes

30 Sep 2025 07:00

RNS Number : 2228B
Nationwide Building Society
30 September 2025
 

 

Nationwide Building Society

 

30 September 2025

 

Nationwide Building Society (Nationwide),Virgin Money UK PLC (Virgin Money) and Clydesdale Bank PLC (Clydesdale Bank) Board Changes

 

Nationwide Building Society announces that, further to the announcement made on 23 May 2025 regarding its intention to align the membership of the Virgin Money and Clydesdale Bank boards with that of Nationwide, the following board changes have been made with effect from 30 September 2025:

 

 

Resignations from the Virgin Money and Clydesdale Bank boards

· Tim Wade - Non-Executive Director, Senior Independent Director and Chair of the Audit Committee

· Lucinda Charles-Jones - Non-Executive Director and Chair of the Remuneration Committee

· Elena Novokreshchenova - Non-Executive Director

· Petra van Hoeken - Non-Executive Director and Chair of the Risk Committee

· Gergely Zaborszky - Executive Director and Chief Financial Officer

 

Appointments to the Virgin Money and Clydesdale Bank boards

· Kevin Parry - Non-Executive Director, Chairman and Chair of the Governance and Nomination Committee

· Tracey Graham - Senior Independent Director Chair of the Remuneration Committee

· Phil Rivett - Non-Executive Director and Chair of the Audit Committee

· Alan Keir - Non-Executive Director and Chair of the Risk Committee

· Albert Hitchcock - Non-Executive Director

· Debbie Klein - Non-Executive Director

· Tamara Rajah - Non-Executive Director

· Gillian Riley - Non-Executive Director

· Sally Orton - Non-Executive Director

· Anand Aithal - Non-Executive Director

· Debbie Crosbie - Executive Director

· Muir Mathieson - Executive Director and Chief Financial Officer

 

Appointment to the Nationwide Board

· Chris Rhodes - Executive Director

 

Chris Rhodes remains CEO of Virgin Money and continues on the Boards of Virgin Money and Clydesdale Bank. Tracey Graham also remains a Non-Executive Director of Virgin Money and Clydesdale Bank. David Bennett will continue as a Non-Executive Director of Nationwide, Virgin Money and Clydesdale Bank until 31 December 2025, after which he will retire from all roles.

 

Kevin Parry OBE, Chairman, said: "The Board changes signify an important step in the bringing together of the Nationwide and Virgin Money businesses enabling the streamlining of decision making and governance across the combined group. I should like to thank the retiring directors for their stewardship of the banks in the period of our ownership."

 

For further information, please contact:

 

Investors and Analysts

Vikas Sidhu

Nationwide.treasury@nationwide.co.uk

Company Secretary

Jason Wright

Jason.wright2@nationwide.co.uk

Media Relations

Sara Batchelor

Press.office@nationwide.co.uk

 

 

About Nationwide Building Society

Nationwide is the world's largest building society as well as one of the largest savings and mortgages providers in the UK. It is also a major provider of current accounts, credit cards, ISAs and personal loans. Nationwide has around 16 million customers and members.

 

Customers can manage their finances in a branch, via the mobile app, on the telephone, internet and post. Nationwide has around 18,000 employees. Nationwide's head office is in Swindon with administration centres based in Northampton, Bournemouth and Dunfermline. Nationwide also has a number of call centres across the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUAPBUPAGUB
Date   Source Headline
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction
20th Nov 202511:47 amRNSPublication of Supplement
20th Nov 20257:00 amRNSInterim Results September 2025
14th Nov 202511:00 amRNSPart VII Transfer
21st Oct 20251:08 pmRNSPublication of Final Terms
10th Oct 202512:52 pmRNSPublication of Final Terms
1st Oct 20257:00 amRNSConfirmation of Post-Offer Intention Statements
30th Sep 202510:03 amRNSBoard Changes
30th Sep 20259:43 amRNSBoard Changes
30th Sep 20257:00 amRNSBoard Changes
26th Sep 20252:49 pmRNSPublication of Final Terms
16th Sep 20251:48 pmRNSPublication of Final Terms
8th Sep 202511:27 amRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.